Top Markets
#1 MON MON +2,759.42%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +44.53%
#4 eCash eCash +31.94%
#5 Siren Siren +24.14%
#6 SAFEcoin SAFEcoin +19.98%
#7 Janction Janction +18.96%
#8 PinGo PinGo +15.88%
#9 Velvet Velvet +15.84%
#10 Decred Decred +12.95%
Coin of the day
MON MON
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Peringkat dalam Saham #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Harga Saham
$0.30780727
Kapitalisasi Pasar
$94.19M
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
-34.73%
Negara
FR
Perdagangan Sensorion SA (ALSEN)

Kategori

Healthcare
Rasio P/S untuk Sensorion SA (ALSEN)
Rasio P/S per July 2026 TTM: 31.10
Menurut laporan keuangan dan harga saham terbaru dari Sensorion SA, rasio P/S saat ini (TTM) adalah 31.10. Pada akhir 2023, rasio P/S perusahaan adalah 10.07.
Riwayat rasio P/S untuk Sensorion SA dari 2011 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 31.10 14.55%
2024 27.15 169.61%
2023 10.07 68.16%
2022 5.99 -83.37%
2021 36.00 -7.10%
2020 38.75 504.07%
2019 6.41 24.60%
2018 5.15 -64.35%
2017 14.44 -99.23%
2016 1.87K 702.80%
2015 233.19 264.53%
2014 63.97 53.97%
2013 41.55 -35.02%
2012 63.94 -99.99%
2011 705.41K 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.26 -86.29%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.29 -66.92%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.31 -86.16%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.44 -79.28%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.96 -45.47%
NL